Alkali-degradation of amyloid: An ancient method useful for making monoclonal antibodies against amyloid fibril proteins

Scandinavian Journal of Immunology

Volumn 70, Issue 6, 2009, Pages 535-540

  Westermark, G T ^a   Sletten, K ^b   Westermark, P ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; AMYLOID; ANTIBODY; FORMALDEHYDE; MONOCLONAL ANTIBODY; PARAFFIN; PWLAM MONOCLONAL ANTIBODY; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SOLUBILIZATION;

ADRENAL GLANDS; ALKALIES; AMYLOID; AMYLOIDOSIS; ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; HYBRIDOMAS; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED BALB C; URINARY BLADDER;

EID: 70449825111     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02336.x     Document Type: Article

References (30)

1. Westermark P, Benson MD, Buxbaum JN et al. A primer of amyloid nomenclature. Amyloid 2007 14 : 179 183.
2. Lachmann HJ, Booth DR, Booth SE et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002 346 : 1786 1791.
3. Enqvist S, Mellqvist U-H, Mölne J et al. A father and his son with systemic AL amyloidosis. Haematologica 2009 94 : 437 439.
4. Arbustini E, Verga L, Concardi M et al. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 2002 9 : 108 114.
5. Solomon A, Murphy C, Westermark P. Misclassification of amyloidosis is unwarranted. Blood 2006 107 : 3489 3491.
6. Murphy CL, Eulitz M, Hrncic R et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Path 2001 116 : 135 142.
7. Olsen KE, Sletten K, Westermark P. The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay. Am J Clin Path 1999 111 : 355 362.
8. Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem 2006 108 : 209 213.
9. Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med 1980 302 : 1283 1292. & 1333-1343.
10. Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 1974 290 : 473 477.
11. Stevens FJ, Weiss DT, Solomon A. Structural basis of light chain-related pathology. In : Zanetti M, Capra JD, eds. The Antibodies. Singapore : Harwood Academic Publishers (Singapore), 1999 : 175 208.
12. Stevens FJ. Four structural risk factors identify most fibril-forming kappa light chains. Amyloid 2000 7 : 200 211.
13. Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 1992 6 : 323 346.
14. Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968 47 : 924 933.
15. Pras M, Zucker-Franklin D, Rimon A, Franklin EC. Physical, chemical and ultrastructural studies of water-soluble amyloid fibrils: comparative analysis of nine amyloid preparations. J Exp Med 1969 130 : 777 795.
16. Ma Z, Westermark GT, Li Z-C, Engström U, Westermark P. Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in the amyloidogenesis. Diabetologia 1997 40 : 793 801.
17. Paulsson JF, Westermark GT. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid production. Diabetes 2005 54 : 2117 2125.
18. Peng S, Glennert J, Westermark P. Medin-amyloid: a recently characterized age-associated arterial amyloid form affects mainly arteries in the upper part of the body. Amyloid 2005 12 : 96 102.
19. Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Meth Enzymol 1999 309 : 3 25.
20. Bergström J, Gustavsson Å, Hellman U et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Path 2005 206 : 224 232.
21. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987 166 : 368 379.
22. Fujihara S, Glenner GG. Primary localized amyloidosis of the genitourinary tract: immunohistochemical study on eleven cases. Lab Invest 1981 44 : 55 60.
23. Linke RP, Oos R, Wiegel NM, Nathrath WB. Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem 2006 108 : 197 208.
24. Röcken C, Eriksson M. Amyloid und Amyloidosen. Pathologe 2009 30 : 182 192.
25. Cathcart ES, Comerford FR, Cohen AS. Immunologic studies on a protein extracted from human secondary amyloid. N Engl J Med 1965 273 : 143 146.
26. Husby G, Natvig JB. Individual antigenic specificity and cross-reactions among amyloid preparations from different individuals. Clin Exp Immunol 1972 10 : 635 647.
27. Westermark P, Natvig JB, Johansson B. Characterization of an amyloid fibril protein from senile cardiac amyloid. J Exp Med 1977 146 : 631 636. (Pubitemid 8138772)
28. Westermark P, Johansson B, Natvig JB. Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol 1979 10 : 303 308.
29. Husby G, Natvig JB. Immunological characterization of amyloid fibrils in tissue sections. Clin Exp Immunol 1972 11 : 357 366.
30. Cornwell GG III., Thomas B, Kyle RA, Sletten K, Westermark P. Immunohistochemical typing of tissues from 100 patients with systemic amyloidosis. In : Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds. Amyloid and Amyloidosis. New York : Plenum Press, 1988 : 179 184.